News

Partner news

19 November 2021

Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement

Read full story

Partner news

19 November 2021

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

Read full story

Partner news

17 June 2021

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story

Partner news

16 February 2021

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story

Partner news

2 February 2021

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story

Partner news

12 January 2021

£10 million research collaboration to detect lung cancer earlier

Read full story

Partner news

5 January 2021

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story

Partner news

5 January 2021

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story